Tag Archives: over

Sanofi loses German patent case against Amgen over cholesterol drug

KARLSRUHE, Germany (Reuters) – Germany’s highest civil court on Tuesday rejected French drugmaker Sanofi’s bid to fend off a legal challenge by U.S. rival Amgen against Sanofi’s cholesterol drug Praluent. In the latest setback for Sanofi in the drawn-out patent dispute with Amgen, which is selling its rival drug Repatha, the German court ruled that… Read More »